Seagen Says Phase 2 Trial of Hodgkin Lymphoma Therapy Showed 'Clinically Meaningful Progression-Free Survival'
Seagen Says Phase 2 Trial of Hodgkin Lymphoma Therapy Showed 'Clinically Meaningful Progression-Free Survival'
西根說，霍奇金淋巴瘤療法的2期試驗顯示 “無進展生存具有臨床意義”
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊